Publications by authors named "Jorg B Engel"

Claim this Profile
E
Effects of an Antagonistic Analog of Growth Hormone-Releasing Hormone on Endometriosis in a Mouse Model and In Vitro.
Frank Köster, Li Jin, Yuanming Shen, Andrew V Schally, Ren-Zhi Cai, Jörg B Engel

Reprod Sci· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer.
Jorg B Engel, Hans-Rudolf Tinneberg, Ferenc G Rick, Enniko Berkes, Andrew V Schally

Curr Drug Targets· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series.
Matthias May, Atiqullah Aziz, Sabine Brookman-May, Florian Roghmann, Joachim Noldus, Jörg B Engel

World J Urol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GHRH-antagonists in TNBC.
Jörg B Engel

Oncotarget· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer.
Jens C Hahne, Antje Kurz, Susanne R Meyer, Johannes Dietl, Jörg B Engel

Arch Gynecol Obstet· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
Stephan Seitz, Stefan Buchholz, Andrew Victor Schally, Florian Weber, Monika Klinkhammer-Schalke, Jörg Bernhard Engel

BMC Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1.
Jörg B Engel, Arnd Honig, Michaela Kapp, Jens C Hahne, Susanne R Meyer

Arch Gynecol Obstet· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS 126 in models of triple-negative breast cancer.
Jens C Hahne, Heike Schmidt, Susanne R Meyer, Jörg B Engel, Johannes Dietl

J Cancer Res Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune escape of AKT overexpressing ovarian cancer cells.
Jens C Hahne, Susanne R Meyer, Stepan Gambaryan, Ulrich Walter, Johannes Dietl, Jörg B Engel

Int J Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosis.
Mathias Krockenberger, Peter Kranke, Sebastian Häusler, Jörg Bernhard Engel, Evi Horn

Anticancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitro.
Jörg B Engel, Theresa Martens, Jens C Hahne, Sebastian F M Häusler, Mathias Krockenberger

Anticancer Drugs· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Search for novel therapies for triple negative breast cancers (TNBC): analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GHRH).
Stefan Buchholz, Stephan Seitz, Jörg B Engel, Alberto Montero, Olaf Ortmann

Horm Mol Biol Clin Investig· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Papillary squamotransitional cell carcinoma of the vagina.
Bernhard Niederle, Stephan Rauthe, Jörg B Engel, Matthias Krockenberger, Johannes Dietl

J Obstet Gynaecol Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
Sebastian F M Häusler, Itsaso Montalbán del Barrio, Jenny Strohschein, P Anoop Chandran, Jörg B Engel

Cancer Immunol Immunother· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical endometriosis associated with malignant pleural mesothelioma mimicking cervical cancer--Occam's razor or the "third man".
Jörg B Engel, Stefan Heuer, Sabine Segerer, Stephan Rauthe, Johannes Dietl

Fertil Steril· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of programmed cell death by inhibition of AKT with the alkylphosphocholine perifosine in in vitro models of platinum sensitive and resistant ovarian cancers.
Jörg B Engel, Tanja Schönhals, Sebastian Häusler, Mathias Krockenberger, Melanie Schmidt

Arch Gynecol Obstet· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors.
Andrew V Schally, Jorg B Engel, Gunter Emons, Norman L Block, Jacek Pinski

Curr Drug Deliv· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage migration inhibitory factor expression in cervical cancer.
Mathias Krockenberger, Jörg B Engel, Julia Kolb, Yvonne Dombrowsky, Sebastian F M Häusler

J Cancer Res Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibition.
Stefan Buchholz, Stephan Seitz, Andrew V Schally, Jörg B Engel, Ferenc G Rick

Int J Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition.
Jörg B Engel, Tanja Schönhals, Claudia Weidler, Sebastian Häusler, Mathias Krockenberger

Oncol Rep· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
Frank Köster, Jörg B Engel, Andrew V Schally, Arnd Hönig, Andreas Schröer

Breast Cancer Res Treat· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
Jörg B Engel, Arnd Honig, Tanja Schönhals, Claudia Weidler, Sebastian Häusler

Eur J Obstet Gynecol Reprod Biol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
Andrew V Schally, Jozsef L Varga, Jörg B Engel

Nat Clin Pract Endocrinol Metab· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones.
Jörg B Engel, Andrew V Schally, Johannes Dietl, Lorenz Rieger, Arnd Hönig

Mol Pharm· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.
Stefan Buchholz, Andrew V Schally, Jörg B Engel, Florian Hohla, Elmar Heinrich

Proc Natl Acad Sci U S A· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis